StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
These are published opinions from external sell-side analysts — not Stonvex recommendations. Ratings may change without notice, may conflict with each other, and may be wrong. Not investment advice.
Consensus aggregated from publicly disclosed sell-side analyst ratings. Stonvex is not a registered investment advisor and does not endorse any of the ratings shown. Past analyst ratings do not predict future price movements.
Indicator values from Polygon. Educational only — single- indicator triggers in isolation are not a complete trading signal.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-18 | $16.32 | $16.58 | +1.59% | 0.3M |
| 05-19 | $16.42 | $16.96 | +3.29% | 0.3M |
| 05-20 | $17.06 | $18.10 | +6.10% | 0.4M |
| 05-21 | $17.80 | $18.74 | +5.28% | 0.6M |
| 05-22 | $18.80 | $18.77 | -0.16% | 0.2M |
CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $26.49M | $89.06M | $64.28M | $41.69M |
Operating Income | $-20.75M | $-58.40M | $-43.81M | $-29.16M |
Net Income | $-19.74M | $-53.41M | $-39.88M | $-13.64M |
EPS (Diluted) | $-0.52 | $-1.46 | $-1.10 | $-0.73 |
Total Assets | $178.08M | $195.80M | $199.53M | $207.69M |
Total Liabilities | $37.27M | $40.47M | $35.44M | $35.53M |
Cash & Equivalents | $45.25M | $40.48M | $23.74M | $40.14M |
Free Cash Flow OCF − CapEx | $-19.42M | $-41.58M | $-30.62M | $-19.16M |
Shares Outstanding | 37.86M | 37.49M | 37.05M | 36.60M |
Latest Form 13F-HR disclosures from the curated Super Investors list. Click through to see each manager's full long book.